CION Ameerpet
Radiation Therapy · Records, Consent & Process Literacy
Clinical Trials Involving Radiation — Should You Join One?
Medically reviewed by Dr. Kirti Ranjan Mohanty, Radiation Oncologist, MBBS · MD (Radiation Oncology), Senior Consultant · Last reviewed August 2026
A clinical trial involving radiation compares a change in technique, dose or schedule against the current standard treatment. You are screened, you read a participant information sheet, you consent, and you are followed more closely than usual. Participation is voluntary. You may withdraw at any time.
- Standard treatment is not withheld — in cancer studies the comparison arm is normally the current standard treatment, not no treatment.
- You can leave whenever you want — withdrawal is a right, you need no reason, and it does not remove your right to standard care.
- Nobody is recruiting you from this page — this is information about how studies work in India so you can read an offer properly, not an invitation to enrol.
- Where your treatment actually happens — your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The short answer
What does joining a radiation clinical trial actually involve?
It means being treated on a written protocol instead of a purely individual plan, and being watched more closely than usual. You are screened against eligibility criteria. You read a participant information sheet and sign consent. Your radiation is then planned and delivered, following the study schedule. Extra visits, scans and questionnaires follow.
What a radiation study usually changes is the schedule, the technique or the sequence — fewer sessions at a higher dose per session, a different way of shaping the beam, or a different order of treatments. What it almost never changes is whether you are treated at all.
The word that frightens people is “experiment”. The more accurate word is “comparison”. A study exists because two reasonable approaches are both in use and nobody yet knows which serves patients better. You are not the first person the approach has been tried on, and you are not being watched to see what happens.
Nothing on this page is a recruitment call. No study is being offered here and nobody is enrolled from this page. This is information about how research works in India so that, if an offer is put in front of you, you can read it properly rather than nod through it.
Where a study is running, your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout — we do not own or operate radiotherapy equipment ourselves.
This page describes general research practice in India. It is patient information, not legal advice, and it does not tell you what your own consent form means. For that, ask the study team and your own treating doctor.
Did you know?
The Clinical Trials Registry – India (CTRI) is run by the ICMR’s National Institute of Medical Statistics, and prospective registration — before the first participant is enrolled — has been the expected standard in India since 2009. The registry is public and searchable, so a study you are offered is something you, or a relative sitting in another country, can look up the same evening.
The fear, answered
Is standard treatment withheld if I join?
No. In cancer studies the comparison arm is normally the current standard treatment. The question being asked is whether a change to it does better — not whether treatment beats nothing. Withholding effective treatment from a person with a treatable cancer is not acceptable practice under Indian or international research ethics guidance.
- Every arm is treated — a study comparing two radiation schedules gives radiation in both. Nobody is assigned to go home untreated so that a difference can be measured.
- A placebo does not replace radiation you need — a dummy treatment is only considered where no established effective treatment exists for that situation, and is normally added on top of standard care rather than substituted for it.
- You are told which arm you may receive before you consent — the participant information sheet has to describe every arm. If it does not, that is a reason to pause, not to sign.
- An ethics committee has already asked this question — a registered ethics committee reviews the design before enrolment opens, and that review exists precisely to stop unacceptable comparisons.
- Saying no changes nothing about your care — declining a study is a normal answer. Your standard treatment proceeds and your team should treat you exactly as before.
Guidance from the ICMR’s national ethical guidelines and the World Medical Association’s Declaration of Helsinki both make the same point: a new approach is tested against the best proven current treatment, not against neglect.
Your exit is built in
Can I leave once I have joined?
Yes, at any point, and you do not owe anyone a reason. Consent to research is treated as a continuing process, not a signature you are held to. You can stop at screening, before the first session, partway through, or during follow-up. Leaving does not remove your right to standard treatment.
- Tell the study coordinator plainly — a sentence is enough. Ask for your withdrawal to be recorded in your file and ask for a copy of that note.
- Ask what happens to treatment already started — if you are mid-course, stopping radiation abruptly is itself a treatment decision. Your radiation oncologist will advise how to finish or adjust safely.
- Ask what happens to data already collected — information gathered before you withdrew is usually kept, and the sheet should say so. Ask whether any further follow-up is expected of you.
- Expect no penalty — withdrawal should not affect your appointments, your relationship with the team, or any scheme or insurance cover you hold.
- Take the pressure off the room — if you feel rushed, that feeling is worth naming out loud. A study team that will not give you time to think is telling you something useful.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Read the sheet with a radiation oncologist beside you
Bring the study document and your reports. We will go through what it says and what it does not — free, confidential, no commitment to join or to leave.
Do this, in this order
How do I decide whether to join a radiation clinical trial?
Seven steps. Most of it is asking, writing down and taking the paperwork home — and the whole point is that you are not asked to decide in the room.
Ask whether a study exists for your exact diagnosis, get the registration number and the ethics committee name, take the information sheet home, and find out what each arm receives. Then count the extra visits, get the cost split in writing, discuss it with family, and answer.
Ask your own team whether a study exists
Most patients are never offered one, because a study has to match the diagnosis, stage and plan precisely. If the answer is no, nothing is wrong with your care.
Get the registration number and the ethics committee name
Ask for the CTRI registration number and the name of the ethics committee that approved the study. Write both down. Neither is a secret.
Take the participant information sheet home
You are entitled to it in a language you understand, and to read it away from the clinic. Nobody should ask you to sign on the same visit.
Ask what each arm actually receives
Ask in plain words what the study is comparing, and whether any participant receives no treatment. Ask them to show you where the sheet says it.
Count the extra visits, scans and forms
Studies add appointments, imaging and questionnaires. Ask how many extra, over how many months, and how far you must travel each time.
Get the cost split in writing
What the study covers, what stays with you or your insurer, and what happens if you withdraw. Ask for it on paper, not as a verbal reassurance.
Discuss it at home, then answer
Talk to the people who will travel with you. Get a second opinion on the underlying plan if you want one. A no is a complete answer.
Not comfortable reading the sheet in English? Ask for a version in your own language and ask your care coordinator to sit with you — Telugu-speaking coordinators do this with district families every week.
Side by side
Standard treatment versus joining a study: what actually changes?
A general comparison of how the two differ in India. Details vary by protocol, so check each line against your own information sheet.
| Question | Standard treatment | Taking part in a study |
|---|---|---|
| Do you receive treatment | Yes — the plan your team judges best for you | Yes — every arm is treated; the comparison arm is normally the current standard |
| Who decides the details | Your radiation oncologist and medical physicist, case by case | The same team, working within a written protocol that fixes some choices in advance |
| What typically varies | Nothing beyond normal clinical judgement | Usually the schedule, the number of sessions, the technique or the sequence |
| Extra scans and visits | Only what your care needs | Additional imaging, blood tests, questionnaires and review visits, for a defined period |
| Cost | Billed to you, your insurer or your scheme in the usual way | Varies by study; some parts may be covered, others not. Ask for the split in writing |
| Oversight | Your treating team and the hospital’s own systems | The same, plus a registered ethics committee and a public registry entry |
| Can you change your mind | Yes — you can decline or pause treatment after discussion | Yes — you may withdraw at any time, with no reason and no loss of standard care |
CION Cancer Clinics is not itself NABH-accredited and does not own radiotherapy equipment. Your radiotherapy is delivered at an NABH-accredited partner centre; CION coordinates your treatment plan, your oncology team and your care throughout.
Why this feels the way it does
Am I being used as a guinea pig?
No — and the feeling usually comes from how the offer was made, not from what was offered. An unfamiliar coordinator, a thick document, a signature requested before you have read it. That sequence makes anyone feel processed rather than informed. The remedy is slowing the process down, not refusing on reflex.
Notice what a study is not. It is not a last resort offered because nothing else can be done. It is not a way of getting cheaper treatment, and it is not a promise of a better result. It aims to answer a question that current evidence has left open.
Notice too what the paperwork is for. The information sheet, the registration entry and the ethics committee exist because research abuse happened in the past, in many countries. They are the scar tissue of that history, and they work in your favour.
If your real doubt is about the underlying treatment plan rather than the study, that is a different request — a clinical second opinion on the plan itself. You can ask for one without leaving your current centre and without giving anyone an answer about the study yet.
Coordinating from Dubai, Sharjah or another city while a parent sits in the clinic in Hyderabad? Ask for the information sheet as a scan, ask for the registration number by message, and join the next consultation on a video call. Both questions — what the study is, and whether the plan under it is right — can be worked through on documents and a call.
One last practical point: whatever you decide, keep your own copy of everything you sign, and keep the study contact number where a family member can find it. This page is general information, not legal advice about your consent form.
Take your time
Nobody should be asked to decide in the room
Whether you are the patient or the relative doing the homework from another city, a radiation oncologist can help you read the offer properly before you answer it.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Clinical trials involving radiation — your questions answered
What does taking part in a radiation clinical trial actually involve?
It means being treated on a defined protocol rather than a purely individual plan, and being followed more closely than usual. You are screened against the eligibility criteria first. You are given a written participant information sheet in a language you understand, and time to read it and ask questions before you sign anything. If you join, your radiation is planned and delivered in the normal way, but the schedule, the technique or the sequence follows the protocol. You then attend extra review visits, and usually extra scans, blood tests and questionnaires, for a defined follow-up period. Everything is recorded in more detail than routine care, and an ethics committee oversees the study while it runs.
Can I leave a clinical trial after I have joined?
Yes. Withdrawal is a right, not a favour, and you do not have to give a reason. Consent in research is treated as a continuing process rather than a single signature, so you can stop at screening, before the first session, partway through treatment, or during the follow-up period. What happens next is a clinical conversation: if you are mid-course, your team will advise how to complete or adjust treatment safely, because stopping radiation abruptly is a treatment decision in its own right. Leaving a study does not remove your right to standard treatment and it should not change how your team looks after you. Say it plainly to the study coordinator and ask for it to be noted in your file.
Is standard treatment withheld if I join a trial?
No. This is the fear that stops most people, and it is the wrong picture. In cancer studies the comparison arm is normally the current standard treatment, and the question being asked is whether a change to it does better, not whether treatment beats nothing at all. Leaving a treatable cancer untreated to create a comparison group is not acceptable practice under Indian and international research ethics guidance. What differs between arms is usually the dose schedule, the number of sessions, the technique, or the order in which treatments are given. Ask the study team to state in plain words what each arm receives, and to show you where it says so in the participant information sheet.
Will I be given a placebo instead of radiation?
A dummy treatment is not used in place of radiation you are known to need. In cancer research a placebo is only considered where there is no established effective treatment for that situation, and even then it is normally added on top of standard care rather than replacing it. A study comparing radiation schedules gives radiation in every arm. If a study you are offered does involve a placebo of any kind, that fact has to be written in the participant information sheet and explained to you before you consent. Ask the question directly, and ask for the answer to be pointed out in the document rather than only spoken.
Who pays for treatment and tests in a clinical trial in India?
It depends entirely on the study, so it has to be asked rather than assumed. Some studies cover the treatment being examined along with the extra scans and tests that exist only because of the research, while routine care continues to be billed as usual to you or your insurer. Others cover very little beyond those extra tests. Indian regulations also require that participants receive care and compensation for injury related to study participation, on terms set out in the consent documents. Ask for a written breakdown of what is covered, what is not, what happens if you withdraw, and whom to contact about a bill. Do not rely on a verbal summary.
How do I check that a trial is properly registered and approved?
Ask for two things: the registration number in the Clinical Trials Registry - India, and the name of the ethics committee that approved the study. Registration before enrolment of the first participant is the expected standard in India, and the registry is publicly searchable, so you can look the study up yourself or ask a relative abroad to do it for you. The participant information sheet should also name a contact person and give a telephone number for questions and complaints. A study team that cannot produce a registration number or an ethics committee name is a study to walk away from. This page is general information about how research is regulated in India, not legal advice.
This page explains, in general terms, how clinical research involving radiation therapy is regulated and conducted in India. It is patient information, not legal advice, and it is not a substitute for guidance from your own oncology team about your diagnosis, your treatment plan or any consent document you are asked to sign.